HROW 8-K 2026-09-04

HARROW, INC. (HROW) 8-K dated 2026-09-04 — accession 0001493152-26-041569. This URL is the filing, not the HROW hub.

HARROW, INC. (HROW) is a drug manufacturers - specialty & generic company listed on US.

HARROW, INC. filed a 8-K on 2026-09-04. Accession 0001493152-26-041569.

Cached items: 5.02, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported HROW revenue for 2025-12-31 was $272.3M. Net income was -$5.1M. Revenue was up 36.4% from 2024-12-31 to 2025-12-31. HROW currently screens at market cap $1.28B.

Not investment advice. The HROW SEC hub lists recent forms. The stock page is the research view.